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Introduction: Medication related adverse events are
common, particularly during transitions of care, and
have a significant impact on patient outcomes and
healthcare costs. Medication reconciliation (MedRec) is
an important initiative to achieve the Quality Use of
Medicines, and has been adopted as a standard
practice in many developed countries. However, the
impact of this strategy is rarely described in Ethiopia.
The aims of this study are to explore patient safety
culture, and to develop, implement and evaluate a
theory informed MedRec intervention, with the aim of
minimising the incidence of medication errors during
hospital admission.
Methods and analyses: The study will be conducted
in a resource limited setting. There are three phases to
this project. The first phase is a mixed methods study
of healthcare professionals’ perspectives of patient
safety culture and patients’ experiences of medication
related adverse events. In this phase, the Hospital
Survey on Patient Safety Culture will be used along
with semi-structured indepth interviews to investigate
patient safety culture and experiences of medication
related adverse events. The second phase will use a
semi-structured interview guide, designed according to
the 12 domains of the Theoretical Domains Framework,
to explore the barriers and facilitators to medication
safety activities delivered by hospital pharmacists. The
third phase will be a single centre, before and after
study, that will evaluate the impact of pharmacist
conducted admission MedRec in an emergency
department (ED). The main outcome measure is the
incidence and potential clinical severity of medication
errors. We will then analyse the differences in the
incidence and severity of medication errors before and
after initiation of an ED pharmacy service.
INTRODUCTION
Patient safety initiatives
Quality patient care is a priority issue in all
healthcare sectors; however, clinical errors
are known to compromise patient safety.1
Patient safety incidents gained attention after
the works of pioneer US studies: the Harvard
Medical Practice Study2 3 and the Institute of
Medicine Report.4 In the USA, it has been
reported that 3.7% of all hospitalised
patients experienced an adverse event,2 and
medication errors alone resulted in 7000
deaths annually.4 Medication errors consti-
tute the most common preventable cause of
patient safety issues, and has been studied
extensively in developed countries.2–6
Despite current advancements in healthcare,
these incidents continue to pose a significant
problem globally,7 and are the concern of
many hospitalists and patient safety activists.
Medication safety in African hospitals
Patient injuries attributed to medication
related adverse events are among the most
common incidents in hospitals,2 and have
important economic and humanistic conse-
quences. Furthermore, given the morbidity
profile and the high burden of malaria,
HIV/AIDS and tuberculosis in Africa, along
with the level of awareness and patient
safety culture, the extent of medication
related adverse events in African hospitals is
thought to be higher than elsewhere in the
world.8 For example, studies have shown
that 1.5–6.5% of hospital admissions are
attributed to adverse drug events
(ADEs),9 10 and 2.5–47% of inpatients
encountered an ADE during their hospital
stay.9 11 One-fifth to more than a half of the
reported ADEs were severe events,10 12–14 of
Strengths and limitations of this study
▪ This is the first study in Ethiopia that will assess
the impact of a pharmacist led medication recon-
ciliation service.
▪ This study is novel in that it uses a behavioural
change theory for implementation of medication
safety programmes.
▪ Multi-method exploration of patient safety issues
will add substantial strength to our study.
▪ The sampling technique in both the interviews
and survey may carry a risk of bias.
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which ADE related fatalities were reported in 0.07–
2.9% of patient admissions to hospital.12 15 16 However,
up to half of the ADEs were due to medication errors
and were preventable.10 The most reported types of
medication errors in African healthcare settings were
prescribing errors, occurring in 13–76% of all prescrip-
tions.17–20 Yet the extent of medication errors and
ADEs have not been fully evaluated in African settings,8
and medication safety programmes designed to prevent
them could represent the first step in improving
patient safety.
Medication reconciliation as a medication safety strategy
More than half of the medication errors occurred at
care transitions, when patients were admitted to, or dis-
charged from, a hospital or transferred to the care of
other healthcare professionals.21 Medication reconcili-
ation (MedRec) as a tool for the prevention of these
errors and consequent patient harm has been advo-
cated internationally.22 23 MedRec has been defined by
the Institute for Healthcare Improvement as “the
process of identifying the most accurate list of a
patient’s current medicines, including the name,
dosage, frequency and route—and comparing them to
the current list in use, recognising and documenting
any discrepancies, thus resulting in a complete list of
medications”.22
Under the leadership of the WHO, patient safety pro-
grammes, including MedRec, have been implemented
across a range of countries23–26 and taken up as health-
care policy. For example, MedRec has been recognised
as a priority patient safety solution by the Australian
Commission on Safety and Quality in Healthcare.26 Prior
to MedRec being routinely practised in Australia, there
was 1 omitted medicine from the medication chart for
every 2 people at hospital admission.27 Also, previous
studies showed that 60–80% of patients had a discrep-
ancy in their medication history.28 29
Studies examining medication errors have been
undertaken in many countries, including developing
nations,30 31 in a range of settings, such as emergency
units,32–38 critical/intensive care units,39 and paediat-
ric40–42 and geriatric units.43–48 There is evidence that
MedRec decreases the frequency of medication
errors49 50 and drug related readmissions.51 52
MedRec with various approaches has been employed
to improve medication safety, including, but not limited
to, technology assisted tools,53–55 use of standardised
forms,34 56 collaborative models,33 57 as well as patient
engagement58 and pharmacist led approaches.59 60
Previous studies have shown benefits from involving
pharmacists in MedRec.59 60 However, the impact of
MedRec overall, as well as pharmacist led MedRec prac-
tice, has not yet been described in sub-Saharan Africa.
Patient safety culture in the Ethiopian context
Despite a lack of research, patient safety in Ethiopia is
believed to be a serious concern. A previous local
study61 in paediatrics ward showed an incidence of 9.2
ADEs per 100 admissions, of which one-third were
deemed preventable. As healthcare managers strive to
improve the quality of patient care, there is a growing
recognition of the importance of establishing a culture
of patient safety. Developing a patient safety culture was
one of the recommendations made by the Institute of
Medicine4 to assist hospitals in improving patient safety.
According to the Agency of Healthcare Research and
Quality (AHRQ),62 patient safety culture is described as
an understanding of the values, beliefs and norms about
what is important in an organisation and what attitudes
and behaviours related to patient safety are supported,
rewarded and expected. Thus it is important for health-
care organisations to assess their patient safety culture to
gain a clear understanding of the patient safety aspects
requiring urgent attention, identify the strengths and
weaknesses of their safety culture,63 and assist hospitals
in identifying their existing patient safety problems.64
Studies on patient safety culture, mostly set in developed
countries,63–66 have been published. However, there are
no data about the current state of the patient safety
culture in Ethiopian hospitals. Furthermore, no studies
have specifically investigated implementation of MedRec
services from a behavioural theory perspective, involving
both barriers and facilitators of a wide range of beha-
vioural determinants in the implementation of evidence
based practice.
This project is a medication safety initiative focusing
on MedRec at care transitions in Ethiopian public hospi-
tals, and implementation of this service is guided by a
multi-method approach consisting of three different but
inter-related studies to inform our study objectives.
Specifically, the aims of this study are: to explore health-
care professionals’ views of patient safety issues, medical
error, and event reporting and patients’ experiences of
medication related adverse events; to use a theoretical
framework to help identify the barriers and facilitators
to medication safety activities delivered by hospital phar-
macists; and to evaluate a pharmacist led MedRec prac-
tice in one of the teaching hospitals in Ethiopia.
METHODS AND ANALYSES
Study setting and period
This is a multi-phased study that is being conducted in
public hospitals in the Amhara region of Ethiopia. The
Amhara region is one of nine regions of Ethiopia
located in the northern part of the country. This region
has an estimated total population of approximately 18
million, with the majority (87.4%) being rural inhabi-
tants. This region has 17 public hospitals, 520 health
centres and 2941 health posts.67
There are three phases to this research project. Phases
1 and 2 are being conducted in 10 selected public hospi-
tals in the Amhara region, including 4 teaching or refer-
ral hospitals (Gondar University, Felege Hiwot, Debre
Markos and Debre Tabor) and 6 district hospitals
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(Metema, Debark, Chagni, Finoteselam, Woldiya and
Enat). Phase 3 will be carried out in one teaching hos-
pital (Gondar University Hospital (GUH)). The study
started in February 2016 and will end in July 2017.
Phase 1: a study of healthcare professionals’ perspectives
of patient safety culture and patients’ experiences of
medication related adverse events
This is a mixed methods study consisting of a survey and
qualitative research. The survey measures dimensional
scores of the patient safety culture. Using a scale to
quantify the scores for patient safety is, however, not
explanatory.68 In addition, a shared decision between
the patient and healthcare professional is central for a
sustainable patient safety culture. Therefore, a survey
supported by an indepth interview is well acknowledged
as a meaningful assessment of patient safety culture
through the eyes of healthcare professionals and
patients.68
Questionnaire study
The survey aims to evaluate the patient safety culture of
public hospitals in the Amhara region. The study focus
is on public hospitals only as most of the population in
the region use public hospitals. The study adopted the
Hospital Survey on Patient Safety Culture (HSOPSC)
developed by AHRQ.69 HSOPSC has been widely used
in assessing patient safety culture and has also been vali-
dated in non-US countries.64 65 The survey consists of 42
items that measure 12 patient safety culture composites:
communication openness, feedback and communication
about errors, frequency of events reported, handovers
and transitions, management support for patient safety,
non-punitive response to error, organisational learning
and continuous improvement, overall perceptions of
patient safety, staffing, supervisor/manager expectations
and actions promoting safety, and teamwork across and
within units. Background characteristics of participants
include questions related to job category, type of hos-
pital (teaching/referral, district), years of working
experience overall and in the current working area,
work setting and working hours per week. The question-
naire is in English, as English is the main language of
communication in Ethiopian hospitals. This question-
naire, together with the participant information state-
ment, was distributed to conveniently selected
healthcare professionals by the research team and
required about 10–15 min to complete. These partici-
pants were recruited from the 10 hospitals in the
Amhara region, and included physicians, nurses, phar-
macists and paramedics (eg, technicians). The sample
size was estimated to be 480, by considering 95% CI, a
5% margin of error and 25% contingency for a non-
response rate, and assuming that patient safety culture
score was rated as excellent in 50% of respondents.
The response to each item in the questionnaire was
assessed using a 5 point Likert scale, where 1 is ‘strongly
disagree’ and 5 is ‘strongly agree’. The patient safety
grade (measured on a scale of excellent, very good,
acceptable, poor and failing) and number of events
reported were the other two outcome variables of inte-
rest. Currently, we are entering the collected data into
SPSS v21, and data will be analysed when data entry is
accomplished. The HSOPSC included both positively
and negatively worded items. For easier interpretation of
the results, AHRQ69 and other studies63–66 recommend
the use of ‘average positive’ for calculating each item
scores—that is, the percentage of positive responses for
each item will be calculated, and negatively worded
items will be reversed when computing per cent positive
response. We will define areas of strength as items for
which 75% of respondents answer positively and areas
requiring improvement as those scoring <50%.62
Additionally, univariate and multivariate analyses will be
conducted to examine statistical associations between
independent characteristics and patient safety grade and
number of events reported. The mean scores for each of
the HSOPSC subscales are taken as dependent variables,
and these will be tested against the independent vari-
ables, such as job characteristics (profession and qualifi-
cation), department and type of hospital (teaching/
referral, district), work experience (career length,
experience in the current unit/hospital) and workload
(working hours).
Indepth interview
The qualitative part of the phase 1 investigation aims to
assess patient safety strategies employed by those hospi-
tals through indepth interviews with different stake-
holders (healthcare professionals and patients) working
in 10 hospitals in the Amhara region. The contact
details of participants (healthcare professionals) were
retrieved from the human resource office or related
office of the respective hospitals. We are using purpose-
ful sampling to identify the initial sample and then the
remaining data collection is being aided by snowball
sampling. We will invite healthcare professionals who are
involved in the care of patients by letter or email, as
appropriate. Patients who are in hospital at the time of
data collection and were taking regular medications
before admission will be invited for interview by a
healthcare professional who is already a participant in
this study. Next, we will contact patients for further invi-
tation into the study. We will employ semi-structured
interviews informed by the interview guide (see online
supplementary additional file 1) for the collection of
data. All interview guides have been translated from the
English versions to the local language (Amharic) by two
non-official translators who are native speakers and
working in the healthcare industry, and validated by two
of the research group (ABM, DM). Interview tools have
been translated to foster faster communication and
expression of ideas.
Before the interview, we will inform respondents about
the aim of the interview, and those who consent will be
given further details on the nature of the study to
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ensure that interviewees understand what is required of
them. We will conduct face to face interviews at a time
and place to suit the participants, and the interviews are
expected to last approximately 30–60 min. We will
forward both open and close ended questions to inter-
viewees to describe their experiences of medication
safety issues and strategies employed to prevent medica-
tion related adverse events. We will encourage partici-
pants to reflect on their own experiences of medication
related adverse events, and we will ask them to think
about an example of a known medication related
adverse event when answering questions.
The interviewer will use prompts when necessary to
encourage further elaboration. We will give 50 Ethiopian
birr to participants in appreciation of their time. All
interviews will be conducted by an English/Amharic
speaking investigator (ABM). We will collect data from
each of the two participant groups until a point of satu-
ration is reached. We will record all interviews using
audiotape with informed consent of participants. After
data collection is completed, the principal investigator
will carry out verbatim Amharic transcriptions of all
interviews, which will then be translated into English,
assigned a unique identifier and imported into a com-
puter programme (Nvivo V10) for qualitative data ana-
lysis. Thematic analysis will then be carried out, and
emerging topics will be identified as themes and
sub-themes.
Phase 2: barriers and facilitators to medication safety
activities delivered by hospital pharmacists
This is a qualitative study using focus group discussions
(FGD) with hospital pharmacists working in selected
public hospitals in the region to gather data on the bar-
riers and facilitators to medication safety activities. We
will employ FGDs in this phase because the interactive
nature of focus groups is specifically important when
group norms and cultural values of particular groups
are of interest, and to explore the degree of consensus
on a given topic,70 including implementation of an
intervention to promote medication safety. Many factors
can affect the adaptability of an evidence based interven-
tion, and the success of implementation efforts depends
on a careful assessment of barriers to, and facilitators
of, the behaviour to be changed.71 A theory based
identification of such factors provides a theoretically
robust evidence base to inform implementation of an
intervention.71 The underpinning theoretical model
used in this study is the Theoretical Domains Framework
(TDF).
Theoretical Domains Framework
Increasing the uptake of evidence into clinical practice
and improving patient outcomes needs behaviour
change. The TDF from health psychology provides the
basis for such an approach, ensuring that a wide range
of possible theoretical explanations for the behaviours
can be considered. Built from 33 behavioural theories,
the TDF was developed to make theories more access-
ible for implementation researchers.72 According to
Michie et al,72 the TDF has 12 domains to explain
behaviour change: (1) knowledge, (2) skills, (3) social/
professional role and identity, (4) beliefs about capabil-
ities, (5) beliefs about consequences, (6) motivation and
goals, (7) memory, attention and decision processes, (8)
environmental context and resources, (9) social influ-
ences, (10) emotion regulation, (11) behavioural regula-
tion and (12) nature of the behaviour. The TDF has
been extensively used to identify barriers to change in
clinical practice to develop interventions.73 74 To justify
implementation of pharmacist led MedRec, it will be
critical to understand the perceived barriers and facilita-
tors underlying the individual pharmacist’s role in medi-
cation safety. Thus this study uses the TDF to develop a
theory informed intervention aimed at improving medi-
cation safety of patients at hospital transitions.
Focus group discussions
In this study, FGDs will be guided by questions designed
based on the TDF (table 1). For each of the 12 domains
that could act as facilitators or barriers to current medi-
cation safety practices and a successful MedRec imple-
mentation, the authors developed several interview
questions. The number of interview questions ranged
between 2 and 5 for each of the 12 domains, for a total
of 43 questions to cover a wide range of constructs
assigned to each domain. The questions were initially
drafted by one researcher (ABM) and then refined by
health service researchers (AJM, JEB) and discussed by
the research team to check for clinical relevance. The
discussion questions will be pilot tested with at least two
hospital pharmacists to assess clarity and focus, and
revised accordingly.
The sample population will be all hospital pharmacists
in the 10 public hospitals across the region. Pharmacists
will be selected using a purposive sampling strategy aug-
mented with snowball sampling. Participants will be
recruited either by letter or email invitation. Participants
willing to be interviewed by sending an email or by
returning a signed consent form will be contacted. The
principal investigator (ABM), who is experienced in
qualitative study, will conduct and facilitate the FGD
using the translated version (Amharic) of the topic
guide. Pharmacists will be encouraged to talk about
internal beliefs and attitudes that may hinder them from
providing clinical pharmacy services, including medica-
tion safety roles. All discussion sessions will be audio-
taped and recorded. Two of the researchers (ABM, ZA)
will read all of the FGD Amharic transcripts, and will be
translated into English. Transcripts will then be coded
based on the 12 domains of the TDF, and thematic
analysis of pharmacists’ statements into the relevant
theoretical domains will be performed.75 Briefly, the
analysis will involve identifying contextualised brief
statements related to the barriers and facilitators to
medication safety activities, categorising statements
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into TDF domains and mapping the underlying theor-
etical constructs within domains. Both inductive and
deductive approaches will be used so as not to miss any
themes. To assess agreement between two researchers,
all extracted themes and sub-themes will be reviewed
in a meeting, and disagreements will be solved
through consensus.
Phase 3: evaluation of the impact of a pharmacist led
MedRec service. Single site before and after study
This phase of the project is the main objective of this
study, and the aim is to investigate the impact of a
pharmacist led MedRec service on the rate and inci-
dence of unintentional medication discrepancies in an
emergency ward of the GUH, Ethiopia. GUH is located
Table 1 Interview guide questions for focus groups according to Michie’s theoretical domains72
Domains Interview questions
Knowledge Are there any hospital guidelines for pharmacists to deliver clinical pharmacy services?
What do you think the level of evidence is for these guidelines?
What do you know about medication reconciliation and review?
What do you think is the level of evidence for medication reconciliation and review?
Can you describe pharmacists’ roles in medication safety activities?
Skills Do you know how to deliver clinical pharmacy services?
Do you know how to deliver medication reconciliation and review services?
Is identification of medication related problems difficult for you?
Have you attended in-service training to deliver clinical pharmacy services?
Social/professional role Is doing medication reconciliation and review compatible with your professional role?
Who is responsible for these services at your hospital?
Do you think hospital guidelines supports your professional roles as a pharmaceutical care
practitioners?
Beliefs about capabilities How easy or difficult do you find performing clinical pharmacy activities?
What problems have you encountered?
How capable are you in performing medication reconciliation and review?
How confident are you that you can do these services despite difficulties?
How comfortable do you feel to undertake these services?
Beliefs about consequences What are the likely positive/negative outcomes of reporting/communicating medication
related problems?
What are the costs of delivering medication reconciliation and review, and what are the
costs of the consequences of these services?
Are you concerned if these services are not provided at your hospital?
Do the benefits of doing these services outweigh the costs?
Does the evidence suggests that doing these services are beneficial?
Motivation and goals How motivated are you to deliver medication reconciliation and review?
Are there incentives to provide these services?
Do you have any other hospital activity that hinders these services?
Memory, attention and decision
processes
Will you consider providing medication reconciliation and review services? If so, how
frequently would you undertake this activity?
How much priority have you given to these services?
Environmental context and
resources
To what extent do physical factors or resources facilitate or hinder delivering medication
reconciliation/review?
Are there competing tasks and time constraints?
Are the necessary resources available to undertake these services?
Do these services have advantages compared with the standard care?
Do government and local authorities provide sufficient support for these services?
Social influences Are clinical pharmacy services in the hospital well acknowledged by other healthcare
professionals?
Do hospital managers acknowledge your role?
Is there any obstruction to these activities in your hospital?
Have you observed others providing these clinical services?
Emotion What things worry you the most in providing medication reconciliation/review services?
To what extent do emotional factors facilitate or hinder these services?
Behavioural regulation Have you received feedback from other healthcare professionals regarding these
services?
What intimal steps are needed to deliver these services?
Nature of the behaviours What do you currently do?
How long are the changes going to take?
Are there any systems in place for sustainable long term changes?
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in Gondar town in the Amhara regional state. It is the
primary hospital in the northwest region of Ethiopia.
GUH provides specialised health services through its
medical and other clinical and diagnostic departments
for a catchment population of approximately 5 million
people.
The sample size calculation is based on the prevalence
of medication errors in previous local studies, which was
identified as 52–58% of all prescriptions.17 76 Assuming
a reduction in medication errors from 55% to 45%, 80%
power, 5% significance level (two sided), we required
127 patients, 51 for the baseline and 76 for the interven-
tion. Hospital discharge statistics showed that this
sample size would be achievable in 3 months. A baseline
assessment of medication discrepancies will thus be con-
ducted for 1 month during hospital admission.
Medication discrepancies are defined as one or more
differences in dosage, frequency, drug or route of
administration, as described by the Institute for
Healthcare Improvement,22 between the current and
previous medication (s) a patient was taking. A pharma-
cist led MedRec intervention will then be carried out
prospectively for 2 months. Inclusion criteria will be
patients >18 years of age, hospitalised for at least
24 hours and taking at least two home/regular medica-
tions on admission.
The standard practice in the current department
involves physicians taking the patient’s medication
history using patient provided information; however, hos-
pital pharmacists do not participate in medication
history taking and prescription review in the emergency
department. The intervention will involve use of the best
possible medication history (BPMH),77 which is based
on a structured interview with the patient about medica-
tion use and retrieving other sources of medication
history, including discharge and referral letters, the
patient’s own medicines and carrier interview. One phar-
macy staff member will be trained in the techinques of
how to get the BPMH by a research pharmacist (ABM).
MedRec will be conducted after patients are informed
of the study and give written consent. Medication use
will be documented within 24 hours of patient admission
through a data collection tool prepared for the purpose
of this study (see online supplementary additional
file 2). The pharmacist will then compare the BPMH
with the admission prescription order of the patient
issued by the physician in charge.
All identified discrepancies will be brought to the
attention of the physician at admission and verification
of these discrepancies will be made—that is, intentional
versus unintentional changes to medications. Intentional
medication discrepancies are medication changes due to
new clinical status of the patient, and are clinically
justifiable but not documented in the patient’s
medical record. Thus only unintentional medication dis-
crepancies (also called as medication errors) will be
reported. The main outcome measure is the incidence
of medication errors and the potential clinical severity
of such errors. The potential clinical severity of medica-
tion errors will be judged by a consensus between a clin-
ical pharmacist and a physician using a tool developed
by Cornish et al.78 Descriptive statistics will be used to
characterise the types of medication errors and the χ2
test will be used to analyse differences in the incidence
and severity of medication errors between the baseline
and intervention groups. Statistical significance is set at
p<0.05.
Ethics and dissemination
The study protocol was approved by the University of
Sydney Human Research Ethics Committee (project No:
2015/818) and the institutional review board of the
University of Gondar, Ethiopia (O/V/P/RCS/05/624/
2016). The data from this study will be disseminated to
researchers, clinicians and health planners in peer
reviewed health journals and conference publications.
One or more meetings will be held locally to give feed-
back to participants and contributors to the study.
DISCUSSION
Patient safety in general, and medication safety in par-
ticular, has become a matter of growing interest and
increasing priority for hospital managers. A safety
culture is a necessary prerequisite for the improvement
of patient safety. However, it is unclear how healthcare
professionals and patients in Ethiopia perceive patient
safety. This study will describe the views of healthcare
professionals in hospitals about patient safety culture
and patients’ experiences of medication related adverse
events, and use a behavioural change theory to imple-
ment a MedRec service. MedRec is a complex interven-
tion conducted across a range of hospital transitions,
and will therefore apply the TDF to a behaviour that is
complex—for example, involving multiple procedures
and conducted by various healthcare professionals.
This study has several strengths. This is the first study
in Ethiopia that will assess the impact of a pharmacist
led MedRec service, and is also novel in that it uses a
theory informed implementation of this new practice as
a medication safety strategy. The use of multi-method
for the exploration of patient safety culture and practice
will add substantial strength to our study. Use of beha-
vioural theory that is commonly used in implementation
studies will allow us to identify and select potentially
relevant domains to target behaviour in detail. This
study will contribute to the knowledge base by providing
more evidence to confirm the importance of MedRec in
improving the Quality Use of Medicines when patients
are admitted to hospital. The challenge of designing
quality improvement projects in resource limited settings
is workload among the staff. We hope the data from this
study will help develop evidence based medication safety
interventions to strengthen the capacity and perform-
ance of hospital pharmacists in settings where resources
are scarce. This study is not without limitations. The
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sampling technique in the qualitative study may carry a
risk of bias by recruiting participants who may have
similar opinions and experiences. To minimise this, par-
ticipants will be requested to nominate other partici-
pants who have different experiences and practice in
medication safety. Moreover, we will use an iterative
process for data collection and analysis for the qualita-
tive studies in phases 1 and 2 until we are sure that there
are no new ideas emerging.
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